Repligen acquires Spectrum LifeSciences for $359 million

Repligen Corp acquired Spectrum, Inc. (Spectrum LifeSciences), a maker of hollow-fiber filtration products and KrosFlo TFF systems, for approximately $359 million ($120 million cash plus $239 million in Repligen stock). The deal closed on August 1, 2017.

“This is a pivotal transaction for Repligen that meets all of our acquisition criteria and is a major step forward in building Repligen as a global leader in bioprocessing.”vectorshift.ai

• 1 source
• vectorshift.aiREPLIGEN CORP acquires Spectrum, Inc. (Spectrum LifeSciences) — deal terms · VectorShift ResearchAug 1, 2017

Summarized from public sources; check the original articles before acting on it.